According to a new report published by Allied Market Research, titled, “Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceuticals), Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) and End user (Hospitals, Ambulatory Surgical Centers, and Others: Global Opportunity Analysis and Industry Forecast, 2021–2030.” According to the analyst of AMR, the global regenerative medicine industry was garnered for $10.10 billion in 2020, and projected to generate $83.19 billion by 2030, growing at a CAGR of 23.4% from 2021 to 2030.
Get Sample PDF Report at: https://www.alliedmarketresearch.com/request-sample/391
- The outbreak of the pandemic has had a positive impact on the global regenerative medicine market. For instance, in 2020, Singapore based Duke-NUS medical school’s emerging infectious disease program demonstrated the utility of immunotherapies in the treatment of COVID-19.
- This drift is most likely to continue post pandemic as well.
Regenerative Medicine Market Overview-
Increase in adoption of stem cell technology, emergence of application of nanotechnology, and rise in prevalence of chronic diseases and trauma emergencies drive the growth of the global regenerative medicine market. On the other hand, certain ethical hurdles and costly treatment associated with regenerative medicines impede the growth to some extent. However, increase in potential in the emerging economies is expected to create lucrative opportunities in the industry.
Regenerative Medicine Market Segmentation:
Synthetic materials segment held the maximum share-
Based on material, the synthetic materials segment held the highest share in 2020, generating nearly one-third of the global regenerative medicine market. This is owing to rise in prevalence of dental disorders among individuals. The pharmaceuticals segment, however, would cite the fastest CAGR of 23.8% from 2021 to 2030.
Cell therapy segment held the highest share-
Based on product type, the cell therapy segment held the major share in 2020, generating more than three-fifths of the global regenerative medicine market. This is due to increase in prevalence of cardiovascular surgeries across the world. The gene therapy segment, on the other hand, is projected to cite the fastest CAGR of 24.7% during the forecast period.
North America held the lion share-
Based on region, the market across North America accounted for the major share in 2020, contributing to nearly half of the global regenerative medicine market. Robust infrastructure provided for research activities and the huge presence of key players across North America boost the market growth. Asia-Pacific, simultaneously, is expected to cite the fastest CAGR of 25.5% throughout the forecast period. Increase in use of regenerative medicine products, surge in R & D activities for new product launch, and rise in investments in the healthcare sector propel the growth of the market.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/391
Regenerative Medicine Market: By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Important Questions Being Answered by the Regenerative Medicine Market Report:
What is the Regenerative Medicine market size and growth?
What are the prominent and latest trends impacting the market?
Which is the largest regional market for Regenerative Medicine?
Key market players discussed in the report include 3M Company, Athersys, Inc., CryoLife, Inc., Integra Lifesciences Corporation, Isto Biologics (Isto Biologics Medical Systems, Inc.), Medtronic plc, Organogenesis Inc., Stryker Corporation, U.S. Stem Cell, Inc., Zimmer Biomet Holdings, Inc.
Top Trending Report:-
Companion Diagnostic Market Size, Share & Growth Outlook 2022-2030
Nuclear Medicine Market Size, Share & Growth Outlook 2022-2030
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest.”
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.